Given the glycemic fluctuations induced by glucagon and the subsequent rebound insulin, diligent glucose level monitoring throughout the test is imperative to detect any early hyperglycemia or late hypoglycemia [31]. This evidence concerns the gene INS and Hypoglycemia.